Annual Drug Patent Expirations for MOVANTIK
Movantik is a drug marketed by Redhill and is included in one NDA. It is available from three suppliers. There are six patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for MOVANTIK.
This drug has ninety-nine patent family members in forty-one countries.
The generic ingredient in MOVANTIK is naloxegol oxalate. Three suppliers are listed for this compound. Additional details are available on the naloxegol oxalate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
